Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03799081
Other study ID # HYMC-00056-18
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 2019
Est. completion date January 2021

Study information

Verified date January 2019
Source Hillel Yaffe Medical Center
Contact Emiliya Ilizirov, MD
Phone 972-532323246
Email emiliyailizirova@gmal.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the use of hysteroscopic embryoscopy or fetoscopy as a powerful diagnostic tool to provide better counseling for couples having experienced pregnancy loss.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date January 2021
Est. primary completion date January 2021
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Women diagnosed with missed abortion during the first trimester of pregnancy

Exclusion Criteria:

- Women diagnosed with missed abortion after the first trimester of pregnancy

- Any contraindication for hysteroscopy

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Fetoscopy
Fetoscopy is a procedure that enables viewing of the fetus through use of a hysteroscope

Locations

Country Name City State
Israel Hille Yaffe Medical Center Hadera

Sponsors (1)

Lead Sponsor Collaborator
Hillel Yaffe Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Macroscopic anatomic malformations in missed abortions The number and type of macroscopic anatomic malformations in missed abortions will be determined through visual observation using a fetoscope Two years
Secondary Minimize intrauterine adhesions through observation To minimize intrauterine adhesions that might occur after curettage through the ability to visualize the womb and pregnancy site through a hysteroscope before the surgical procedure so that inadvertent intrauterine adhesions are minimized. After one year, if pregnancy is not achieved (due to intrauterine adhesions that cause infertility), a follow-up hysteroscopy will be performed and intrauterine adhesions can be visualized if they have occurred. Two years
Secondary Prevention of retained conception products Prevention of retained conception products by hysteroscopy after curettage and visualization and observation of the contents of the womb Two years
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04499976 - Isonicotinic Acid Hydrazide Pretreatment With Misoprostol Induction of Abortion in First-trimester Missed Miscarriage Phase 4
Active, not recruiting NCT03736681 - Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage Phase 1
Completed NCT03636451 - Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o Phase 3
Recruiting NCT05124314 - Comparison of Two Different Drug Regimens for Medical Treatment of Early Pregnancy Loss Phase 4
Recruiting NCT02917785 - Testing the Efficiency of Karman Curette in the Treatment of Misoprostol Failure in Women With Missed Abortion N/A
Completed NCT04906278 - Amniotomy for Second-trimester Pregnancy Termination N/A
Completed NCT03148314 - Vaginal Misoprostol In Management Of First Trimester Missed Abortion. Phase 2
Completed NCT00784797 - Misopristol Versus Pitocin for Second Trimester Abortion Phase 4
Completed NCT03767179 - Research of Serum Procalcitonin, ESR, CRP And Leukocyte Levels in Fertile Missed Abortion Cases
Completed NCT02515604 - Comparison of Single and Repeated Dose of Vaginal Misoprostol for the Treatment of Early Pregnancy Failure Phase 4
Completed NCT00410345 - Cervical Rippening With Antiprogesterone in Midtrimester Abortions Phase 4